Acute Disseminated Encephalomyelitis
On this page
Overview
Acute Disseminated Encephalomyelitis (ADEM) is a neurological disorder that causes a short and sudden inflammatory attack in the brain and spinal cord. This attack damages the myelin sheath — the fatty tissue that protects nerve cells in the same way that insulation protects electrical wiring in a house. Myelin also helps nerve fibers conduct electrical impulses to and from the brain. Conditions that cause damage to the myelin sheath are called demyelinating disorders.
ADEM is the most common demyelinating disorder in children. The condition may occur after a child has a viral infection or after vaccination for measles, mumps or rubella, though in some cases, there is no proceeding cause. The prognosis for children who develop ADEM varies. In many cases, with proper treatment, recovery begins within days of the attack.
Our Regional Pediatric Multiple Sclerosis Center specializes in the care of children and adolescents with ADEM and related demyelinating diseases.
Signs & symptoms
Symptoms of acute disseminated encephalomyelitis, or ADEM, are similar to multiple sclerosis. As a result, the disease is often misdiagnosed as a severe attack of multiple sclerosis. There are key differences, however, between the symptoms of ADEM and MS, which can be recognized by a neurologist.
Initial symptoms of ADEM occur quickly and intensely as a single, short-lived attack, though some children experience recurrent episodes over a period of months. Symptoms may include:
- Fatigue
- Fever
- Headache
- Nausea
- Vomiting
Changes in your child's consciousness — such as seizures or in severe cases, coma — as well as behavioral changes such as irritability are also likely.
Other symptoms are caused by myelin damage and include:
- Difficulty coordinating muscle movements
- Visual disturbances
- Weakness of a single limb or one side of the body
Diagnosis
An accurate and early diagnosis of acute disseminated encephalomyelitis, or ADEM, is critical in the management of your child's disease and quality of life.
In making a diagnosis, your child's doctor will first conduct a thorough physical examination, asking about symptoms your child is experiencing, including when they started and how they've eased or progressed over time. Your child's doctor also will record a full medical history, including information about your immediate and extended family.
Next, a series of tests will be conducted, including magnetic resonance imaging (MRI) of the brain and spinal cord to look for lesions, or areas of damage that may indicate ADEM and rule out other disorders such as multiple sclerosis. An MRI scan is a non-invasive procedure that uses powerful magnets to construct clear, detailed pictures of the brain and spinal cord tissues.
Recent brain lesions are more typical in ADEM, but can also occur in multiple sclerosis.
Old "inactive" lesions usually indicate multiple sclerosis, which often causes brain lesions before symptoms become obvious.
Your child also may have a lumbar puncture or spinal tap to determine if there are abnormalities in the cerebrospinal fluid or CSF.
CSF is the fluid that bathes, cushions and protects the brain and spinal cord. It flows through the skull and spine in the subarachnoid space, which is the area inside the arachnoid membrane. Typically, in ADEM, a child's CSF contains elevated levels of white blood cells and protein.
A diagnosis of ADEM is based on an evaluation of your child's symptoms along with the physical exam and test results.
Treatment
Children and adolescents with acute disseminated encephalomyelitis or ADEM receive treatment at our Pediatric Multiple Sclerosis Center. Our experts specialize in ADEM and related diseases and work with each child to develop a unique treatment plan, including long-term follow-up care specifically tailored to his or her needs.
When necessary, we collaborate with other specialists at UCSF or elsewhere to ensure your child receives the most comprehensive care possible. Because we are part of an international network of six pediatric MS centers sponsored by the National Multiple Sclerosis Society, we have access to the latest information, research and treatments.
The majority of children with ADEM will respond partially or completely to corticosteroid therapy, which diminishes symptoms by suppressing inflammation in the brain and spinal cord.
If corticosteroids fail, other treatments may be prescribed including:
- Immunosuppressive therapy, which is treatment to reduce or deactivate the immune system
- Intravenous immunoglobulin therapy, which is the administration of antibodies extracted from plasma
- Plasmapheresis, which is the removal, treatment and return of blood plasma
Your child's treatment may include other medications to treat symptoms as well as supportive care to help your child recover both physically and mentally, which may take weeks to months.
Some children experience problems with their memory, especially short-term memory. They also may experience emotional disturbances.
Rest alternated with mental and physical exercise is recommended for your child's rehabilitation. Our team of experts includes a physical therapist, speech therapist and neuropsychologist who will work with your child to recover.
Awards & achievements
Research initiatives
Lorem ipsum odor amet consectetuer adipiscing elit viverra loremOpens in a new window
Lorem ipsum odor amet, consectetuer adipiscing elit. Viverra posuere tincidunt augue dui ligula. Pretium senectus fermentum viverra feugiat congue potenti purus. Ac duis dui ligula lorem nasceturLorem ipsum dolor sit
Lorem ipsum odor amet, consectetuer adipiscing elit. Viverra posuere tincidunt augue dui ligula. Pretium senectus fermentum viverra feugiat congue potenti purus. Ac duis dui ligula lorem nascetur.
Clinical trials
Hyperpolarized Carbon Metabolic Imaging in Multiple SclerosisOpens in a new window
Recruiting
Percent changes in lesion HP 13C pyruvate metabolism measures. The following metabolism measures will be assessed at baseline and at 1.5-months following treat...Care in Multiple Sclerosis (MS)Opens in a new window
Recruiting
Severity of MS will be measured by MRI FLAIR lesion volume among Aim 2 participants."Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MSOpens in a new window
Recruiting
The investigators will optimize key metrics until they show at least 0.75 correlation coefficient with MSFC z scores, as well as individual domains (walking sp...Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyOpens in a new window
Recruiting
The efficacy of clemastine relative to placebo at increasing the myelin water fraction (MWF) (measured in %) from magnetic resonance imaging of the corpus call...
